Could 'Good' eye bacteria ease dry eye? new trial launches
NCT ID NCT07298811
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tests whether transplanting healthy bacteria from the eye's surface can help people with moderate to severe dry eye. Forty participants will either receive the bacteria transplant or a fake procedure. Researchers will measure changes in eye discomfort and surface damage over time.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Ocular surface microbiota transplantation
- What this could lead to
- If it works, this could offer a new way to manage dry eye by restoring healthy bacteria on the eye's surface.
- What could go wrong
- This is a very early, small trial (40 people) testing safety and basic effectiveness. The approach is novel and may not provide lasting relief or work for everyone.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DRY EYE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Yifeng Yu
RECRUITINGNanchang, Jiangxi, 330008, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can insulin eye drops quench dry eyes?
- Can a new eye drop soothe severe dry eye?
- New imaging tools put to the test for measuring dry eye treatment effects
- Could a special screen light reduce tired eyes and dryness?
- Nasal spray could make contact lenses more comfortable
- Dry eye drops may sharpen cataract surgery outcomes